Is ischemia-modified albumin a reliable tool for the assessment of acute pancreatitis?
Open Access
- 1 March 2018
- journal article
- research article
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 14, 627-635
Abstract
Purpose: Oxidative stress has been implicated in several disorders, including acute pancreatitis (AP). Ischemia-modified albumin (IMA), which reflects the ability to bind cobalt, has been found to be elevated in conditions of oxidative stress and tissue hypoxia. This study examined IMA and adjusted IMA levels in patients with AP, and examined the associations of IMA and adjusted IMA levels to the severity of AP. Patients and methods: A total of 42 consecutive patients with AP and 43 age- and sex-matched control subjects were enrolled. Serum samples were obtained from patients with AP on admission as well as 48–72 hours after hospitalization, and from the controls, at the time of enrollment. Adjusted IMA was calculated by multiplying the IMA value of each patient with the ratio of the patient’s albumin value and the median albumin value of the study population. The severity of AP was assessed according to the modified Atlanta classification, and the patients were divided into 2 groups: mild AP and severe AP. Results: The serum IMA and adjusted IMA values of patients with AP on admission and those of the controls did not differ (p=0.86 and p=0.99, respectively). The second measurements of IMA and adjusted IMA in the AP group were higher than the first measurements of both the AP group and controls (for all, pp=0.005). Conclusion: It was shown that IMA and adjusted IMA levels rise with the progression of AP. Lower levels of adjusted IMA predict the severity of AP. Further studies with serial measurements of IMA are warranted to explore the indicative role of IMA in the course of AP.Keywords
This publication has 38 references indexed in Scilit:
- Redox signaling in acute pancreatitisRedox Biology, 2015
- Evaluation of albumin structural modifications through cobalt-albumin binding (CAB) assayJournal of Pharmaceutical and Biomedical Analysis, 2014
- The Epidemiology of Idiopathic Acute Pancreatitis, Analysis of the Nationwide Inpatient Sample From 1998 to 2007Pancreas, 2013
- Effect of albumin concentration and serum matrix on ischemia-modified albuminClinical Biochemistry, 2010
- Acute pancreatitis at the beginning of the 21st century: The state of the artWorld Journal of Gastroenterology, 2009
- Ischemia Modified Albumin: A Novel Biomarker for the Detection of Cardiac IschemiaDrug Metabolism and Pharmacokinetics, 2009
- Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary studyThe American Journal of Emergency Medicine, 2008
- Ischemia-Modified Albumin Predicts Mortality in ESRDAmerican Journal of Kidney Diseases, 2006
- Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin: Table 1Heart, 2005
- A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary reportThe Journal of Emergency Medicine, 2000